Adarsh b.r. Project
-
Upload
amit-verma -
Category
Documents
-
view
233 -
download
0
Transcript of Adarsh b.r. Project
-
8/2/2019 Adarsh b.r. Project
1/17
-
8/2/2019 Adarsh b.r. Project
2/17
CERTIFICATE
This is to certify that Project entitled GMP Guidelines submitted to B.R. Nahata College of
Pharmacy, is a bonafide work carried out by Mr.Adarsh Sahu for the Diploma in Quality
Assurance under my guidance during the academic year 2010-2011.
Mrs. Anurekha Jain
H.O.D Pharmacognosy
B.R.Nahata
-
8/2/2019 Adarsh b.r. Project
3/17
Affectionally dedicatedTo
My beloved Parents&
Family
-
8/2/2019 Adarsh b.r. Project
4/17
ACKNOWLEDGEMENT
Let me express my profound sense of gratitude and heart full thanks to my esteemed project guide Mrs.
Anurekha Jain, for her tolerance in every step, keen interest, regular observations, kind co-operation,
boundless enthusiasm, affectionate encouragement, simulative and constructive criticism, throughout this
work has brought up this dissertation entitling "GMP Guidelines" into this shape. Words fail to express my
real feelings of obligation regarding his cool mentality at much hard times.
With pride and pleasure, I wish to express my thanks toH.O.D & faculty members of B.R.Nahata
mandsaur for his valuable help and providing me the necessary facilities to carry out this work with great
ease and precision.
I wish to offer my respectable thanks to him, for their support and encouragement throughout my
dissertation work. At inception I am confessing to all my well-wishers, whose name not mentioned in these
pages and I express my sincere thanks to all those who were instrumental both directly and indirectly in
completing my dissertation work successfully.
Mr. Adarsh Sahu
Contents
1. Introduction
-
8/2/2019 Adarsh b.r. Project
5/17
A. Objective
B. Regulatory Applicability
C. Scope
2. Good manufacturing practices (GMP)
3. QUALITY MANAGEMENT
A. Principles
B. Responsibilities of the Quality Unit
C. Responsibility for Production Activities
D. Internal Audits (Self Inspection)
E. Product Quality Review
4. PERSONNEL
4. Validation
5. Protocols
6. Master validation plan
7. Change control
8. Facility systems and equipment
9. Format for an installation qualification protocol
1. Introduction
-
8/2/2019 Adarsh b.r. Project
6/17
Good manufacturing practice" or "GMP" are practices and the systems required to be adapted inpharmaceutical manufacturing, quality control, quality system covering the manufacture andtesting of pharmaceuticals or drugs including active pharmaceutical ingredients, diagnostics,foods, pharmaceutical products, and medical devices. GMPs are guidance that outline the aspectsof production and testing that can impact the quality of a product. Many countries have legislatedthat pharmaceutical and medical device companies must follow GMP procedures, and havecreated their own GMP guidelines that correspond with their legislation, basic concepts of all theseguidelines remains more or less similar that is ultimate goal to safeguard the health of the patient,producing a good quality medicine or medical devices or active pharmaceutical products, in U.Sthe drug may be deemed by law as adultrated even if it passes all the specifications tests but isfound to be manufactured in condition which violates current good manufacturing guidelines,therefore complying with gmp is a mandatory aspect in pharmaceutical manufacturing.
Although there are a number of them, all guidelines follow a few basic principles.
Manufacturing processes are clearly defined and controlled. All critical processes are validated to
ensure consistency and compliance with specifications.
Manufacturing processes are controlled, and any changes to the process are evaluated. Changesthat have an impact on the quality of the drug are validated as necessary.
Instructions and procedures are written in clear and unambiguous language. (Good Documentation
Practices)
Operators are trained to carry out and document procedures.
Records are made, manually or by instruments, during manufacture that demonstrate that all the
steps required by the defined procedures and instructions were in fact taken and that the quantity
and quality of the drug was as expected. Deviations are investigated and documented.
Records of manufacture (including distribution) that enable the complete history of a batch to be
traced are retained in a comprehensible and accessible form.
The distribution of the drugs minimizes any risk to their quality. A system is available for recalling any batch of drug from sale or supply.Complaints about marketed
drugs are examined, the causes of quality defects are investigated, and appropriate measures are
taken with respect to the defective drugs and to prevent recurrence.
A. Objective
This document is intended to provide guidance regarding good manufacturing practice (GMP) for
themanufacturing of active pharmaceutical ingredients (APIs) under an appropriate system for managing
quality. It is also intended to help ensure that APIs meet the quality and purity characteristics that they
purport, or are represented, to possess.
In this guidance, the term manufacturing is defined to include all operations of receipt of
materials,production, packaging, repackaging, labeling, relabeling, quality control, release, storage and
distribution of APIs and the related controls. In this guidance, the term shouldidentifies recommendation
that, when followed, will ensure compliance with CGMPs. An alternative approach may be used if such
approach satisfies the requirements of the applicable statutes. For the purposes of this guidance, the
terms current good manufacturing practices and good manufacturing practices are equivalent.mpany's
responsibility to determine the most effective and efficient quality process.
http://en.wikipedia.org/wiki/Foodshttp://en.wikipedia.org/wiki/Pharmaceuticalhttp://en.wikipedia.org/wiki/Medical_deviceshttp://en.wikipedia.org/wiki/Good_Documentation_Practicehttp://en.wikipedia.org/wiki/Good_Documentation_Practicehttp://en.wikipedia.org/wiki/Good_Documentation_Practicehttp://en.wikipedia.org/wiki/Good_Documentation_Practicehttp://en.wikipedia.org/wiki/Medical_deviceshttp://en.wikipedia.org/wiki/Pharmaceuticalhttp://en.wikipedia.org/wiki/Foods -
8/2/2019 Adarsh b.r. Project
7/17
This guidance document has been prepared to aid vaccine manufacturers in the preparation and
performance of the validation studies required by Good Manufacturing Practices (GMP) of the World
Health Organization (WHO). The WHO GMP publications,other GMP Regulations/Guidelines and many
publications on the concept andprocess of validation for pharmaceutical manufacture were consulted
during preparationof the Guide.
B. Regulatory Applicability
Within the world community, materials may vary as to their legal classification as an API. When a
material is classified as an API in the region or country in which it is manufactured or used in a drug
product, it should be manufactured according to this guidance.
C. Scope
This guidance applies to the manufacture of APIs for use in human drug (medicinal) products. It applies to
the manufacture of sterile APIs only up to the point immediately prior to the APIs being rendered sterile.
The sterilization and aseptic processing of sterile APIs are not covered by this guidance, but should be
performed in accordance with GMP guidances for drug (medicinal) products as defined by local authorities.
2. Good manufacturing practices (GMP)
WHO defines Good Manufacturing Practices (GMP) as that part of quality assurance
which ensures that products are consistently produced and controlled to the quality
standards appropriate to their intended use and as required by the marketing authorization.
GMP covers all aspects of the manufacturing process: defined manufacturing
process; validated critical manufacturing steps; suitable premises, storage, transport;
qualified and trained production and quality control personnel; adequate laboratory
facilities; approved written procedures and instructions; records to show all steps of
defined procedures have been taken; full traceability of a product through batch records
and distribution records; and systems for recall and investigation of complaints.
The guiding principle of GMP is that quality is built in to a product, and not just tested
in to a product. Therefore, the assurance is that the product not only meets the final
specifications, but that it has been made by the same procedures under the same conditions
each and every time it is made. There are many ways this is controlled - validation
is that part of GMP that ensures that facility systems, equipment, processes, and
-
8/2/2019 Adarsh b.r. Project
8/17
tests procedures are in control and therefore consistently produce quality product.
3.Quality management
A. Principles
Quality should be the responsibility of all persons involved in manufacturing.
Each manufacturer should establish, document, and implement an effective system for managing quality
that involves the active participation of management and appropriate manufacturing personnel.
The system for managing quality should encompass the organizational structure, procedures, processes
and resources, as well as activities to ensure confidence that the API will meet its intended specifications
for quality and purity. All quality-related activities should be defined and documented. There should be a
quality unit(s) that is independent of production and that fulfills both quality assurance (QA) and quality
control (QC) responsibilities. The quality unit can be in the form of separate QA andQC units or a single
individual or group, depending upon the size and structure of the organization.
The persons authorized to release intermediates and APIs should be specified.
All quality-related activities should be recorded at the time they are performed.
Any deviation from established procedures should be documented and explained. Critical deviations
should be investigated, and the investigation and its conclusions should be documented.
No materials should be released or used before the satisfactory completion of evaluation by the quality
unit(s) unless there are appropriate systems in place to allow for such use
B. Responsibilities of the Quality Unit(s)
The quality unit(s) should be involved in all quality-related matters.
The quality unit(s) should review and approve all appropriate quality-related documents.
the main responsibilities of the independent quality unit(s) should not be delegated. These
responsibilities should be described in writing and should include, but not necessarily be limited to:
1. Releasing or rejecting all APIs. Releasing or rejecting intermediates for use outside the
control of the manufacturing company
2. Establishing a system to release or reject raw materials, intermediates, packaging, and
labeling materials.
-
8/2/2019 Adarsh b.r. Project
9/17
3. Reviewing completed batch production and laboratory control records of critical
process steps before release of the API for distribution.
4. Making sure that critical deviations are investigated and resolved
5. Approving all specifications and master production instructions
6. Approving all procedures affecting the quality of intermediates or APIs
7. Making sure that internal audits (self-inspections) are performed
8. Approving intermediate and API contract manufacturers
9. Approving changes that potentially affect intermediate or API quality
10. Reviewing and approving validation protocols and reports
11. Making sure that quality-related complaints are investigated and resolved
12. Making sure that effective systems are used for maintaining and calibrating critical
equipment
13. Making sure that materials are appropriately tested and the results are reported
14. Making sure that there is stability data to support retest or expiry dates and storage
conditions on APIs and/or intermediates, where appropriate
15. Performing product quality reviews
C. Responsibility for Production Activities
The responsibility for production activities should be described in writing and should include, but not
necessarily be limited to:
1. Preparing, reviewing, approving, and distributing the instructions for the production of
intermediates or APIs according to written procedures
2. Producing APIs and, when appropriate, intermediates according to pre-approvedinstructions
3. Reviewing all production batch records and ensuring that these are completed and signed
4. Making sure that all production deviations are reported and evaluated and that critical
deviations are investigated and the conclusions are recorded
-
8/2/2019 Adarsh b.r. Project
10/17
5. Making sure that production facilities are clean and, when appropriate, disinfected
6. Making sure that the necessary calibrations are performed and records kept
7. Making sure that the premises and equipment are maintained and records kept
8. Making sure that validation protocols and reports are reviewed and approved
9. Evaluating proposed changes in product, process or equipment
10. Making sure that new and, when appropriate, modified facilities and equipment are Qualified
D. Internal Audits (Self Inspection)
To verify compliance with the principles of GMP for APIs, regular internal audits should be performed
in accordance with an approved schedule.
Audit findings and corrective actions should be documented and brought to the attention of responsible
management of the firm. Agreed corrective actions should be completed in a timely and effective
manner.
E. Product Quality Review
Regular quality-reviews of APIs should be conducted with the objective of verifying the consistency of
the process. Such reviews should normally be conducted and documented annually and should include
at least:
A review of critical in-process control and critical API test results
A review of all batches that failed to meet established specification(s)
A review of all critical deviations or nonconformances and related investigations
A review of any changes carried out to the processes or analytical methods;
A review of results of the stability monitoring program
A review of all quality-related returns, complaints and recalls
3. Validation
Validation is defined as the establishing of documented evidence which provides a high
degree of assurance that a planned process will consistently perform according to the
-
8/2/2019 Adarsh b.r. Project
11/17
intended specified outcomes. Validation studies are performed for analytical tests,
equipment, facility systems such as air, water, steam, and for processes such as the
manufacturing processes, cleaning, sterilization, sterile filling, lyophilization, etc. There
will be a separate validation for the lyophilizer as an equipment item and for the lyophilization
process; for the cleaning of glassware and the cleaning of the facility; and
for the sterilization process and for the sterility test. Every step of the process of
manufacture of a drug product must be shown to perform as intended. Validation
studies verify the system under test under the extremes expected during the process to
prove that the system remains in control. Once the system or process has been validated,
it is expected that it remains in control, provided no changes are made. In the
event that modifications are made, or problems occur, or equipment is replaced or
relocated, revalidation is performed. Critical equipment and processes are routinely
revalidated at appropriate intervals to demonstrate that the process remains in control.
The validity of systems/equipment/tests/processes can be established by prospective,
concurrent or retrospective studies. Prospective validation is data collected based on a
pre-planned protocol. This is the most controlled method and is the validation approach
presented in this Guide.
4. PERSONNEL
A. Personnel Qualifications)
There should be an adequate number of personnel qualified by appropriate education, training, and/or
experience to perform and supervise the manufacture of intermediates and APIs.
-
8/2/2019 Adarsh b.r. Project
12/17
The responsibilities of all personnel engaged in the manufacture of intermediates and APIs should be
specified in writing.
Training should be regularly conducted by qualified individuals and should cover, at a minimum, the
particular operations that the employee performs and GMP as it relates to the employee's functions.
Records of training should be maintained. Training should be periodically assessed.
B. Personnel Hygiene
Personnel should practice good sanitation and health habits.
Personnel should wear clean clothing suitable for the manufacturing activity with which they are involved
and this clothing should be changed, when appropriate. Additional protective apparel, such as head,
face, hand, and arm coverings, should be worn, when necessary, to protect intermediates and APIs
from contamination.
Personnel should avoid direct contact with intermediates or APIs.
Smoking, eating, drinking, chewing and the storage of food should be restricted to certain designated areas
separate from the manufacturing areas.
Personnel suffering from an infectious disease or having open lesions on the exposed surface of the body
should not engage in activities that could result in compromising the quality of APIs. Any person shown atany time (either by medical examination or supervisory observation) to have an apparent illness or open
lesions should be excluded from activities where the health condition could adversely affect the quality of
the APIs until the condition is corrected or qualified medical personnel determine that the person's
inclusion would not jeopardize the safety or quality of the APIs.
C. Consultants
Consultants advising on the manufacture and control of intermediates or APIs should have sufficient
education, training, and experience, or any combination thereof, to advise on the subject for which they
are retained.
5. Protocols
A protocol is a written set of instructions broader in scope than a Standard Operating
Procedure (SOP). SOPs are the detailed written instructions for procedures routinely
performed in the course of any of the activities associated with pharmaceutical manufacturing.
-
8/2/2019 Adarsh b.r. Project
13/17
A protocol describes the details of a comprehensive planned study to investigate
the consistent operation of new system/equipment, a new procedure, or the
acceptability of a new process before it is implemented. Protocols include significant
background information, explain the rationale for and the objective of the study, give a
full description of the procedures to be followed, set out the parameters to be measured,
describe how the results will be analyzed, and provide pre-determined acceptance
criteria for making conclusions. Validation studies, stability studies, and clinical
studies are examples of written protocols for pharmaceutical manufacturers. Validation
protocols are important in ensuring that documented evidence is taken which
demonstrates that an equipment item, a system, a process or a method consistently
performs at a specified level.
6. Master validation plan
The Master Validation Plan is a document pertaining to the whole facility that describes
which equipment, systems, methods and processes will be validated and when
they will be validated. The document should provide the format required for each
particular validation document (Installation Qualification, Operational Qualification
and Performance Qualification for equipment and systems; Process Validation; Analytical
Assay Validation), and indicate what information is to be contained within each
document. Some equipment requires only installation and operational qualifications,
and various analytical tests need to establish only some performance parameters - this
must be explained in the master protocol along with some principles of how to determine
which of the qualifications are required by each, and who will decide what validations
will be performed.The Master Validation Plan should also indicate why and when revalidations will be
performed, either after changes or relocation of equipment or systems; changes to
processes or equipment used for processing; or for changes in assay methods or in
-
8/2/2019 Adarsh b.r. Project
14/17
equipment used in tests.
If a new process or system is implemented, a Design Qualification (DQ) may be necessary.
Guidelines for such cases should be included in the Master Validation Plan. A
Design Qualification would be necessary when planning and choosing equipment or
systems to ensure that components selected will have adequate capacity to function for
the intended purpose, and will adequately serve the operations or functions of another
piece of equipment or operation. For example: i) a water system must produce sufficient
water of specified quality to serve the requirements of the facility including production,
testing, and as a source for steam or for a second system producing higher
quality water; ii) a steam generator must produce sufficient steam of the correct quality
to fulfill all the autoclaving needs and Steam-in-Place (SIP) cleaning procedures of the
facility; or iii) the equipment chosen for a particular operation must have sufficient
space and access for proper cleaning operations and maintenance.
The order in which each part of the facility is validated must be addressed in the Master
Validation Plan. For example the water system should be validated before validating a
piece of equipment that uses this water system. The IQ, OQ and PQ must be performed
in order: the master validation plan should indicate how to deal with any
deviations from these qualifications, and state the time interval permitted between each
validation.
6. Change control
A qualification/validation study is designed for defined parameters and measures specified
outcomes. Any modifications made to equipment, systems, processes or procedures
may change the parameters or affect the expected outcomes. Therefore any
-
8/2/2019 Adarsh b.r. Project
15/17
change that is made after initial validation is complete must be controlled. Change
control must be a formal process following a pre-determined procedure set out in a
Quality Assurance document (e.g. a QA SOP or in the Master Validation Plan). The
change control procedure should include the planning and submission of a proposal
for the change with a rationale and anticipated impact on the function, operation or
performance. The proposal should be prepared by the department requesting the change
and reviewed and approved by QA, management and other appropriate departments
(change control team). The effect of the change on the specific system/process under
consideration as well as the wider implication for other systems and processes of the
facility. Re-validation of the system/process or other systems may be necessary depending
on the significance of the change. No changes should be made for any validated,
approved equipment/systems/tests/processes without formal review and approval
via the change control procedure.
7. Facility systems and equipment
The validation protocols for equipment and systems are normally divided into three
segments: Installation Qualification, Operational Qualification and Performance Qualification,
abbreviated as IQ, OQ, PQ. For systems and equipment, Performance Qualification
is often synonymous with Validation. Depending on the function and operation
of some equipment, only IQ/OQ are required. For equipment whose correct
operation is a sufficient indicator of its function, and that are monitored and/or calibrated
on a regular schedule (e.g. pH meter, incubator, centrifuge, freezer), the installation
and operational qualifications are performed. Systems such as air, water, steam,
and major equipment which perform critical support processes, such as sterilization
(autoclave, oven), depyrogenation (oven or tunnel), or lyophilization, require installation,
operational and performance qualifications.
-
8/2/2019 Adarsh b.r. Project
16/17
The following table lists the typical categories of systems and equipment which require
performance qualification
Systems Equipment
Air (HVAC) Autoclave
Compressed air Depyrogenation oven or tunnel
Pure Steam Lyophilizer
Raw steam Continuous flow centrifuge
Purified water
WFI
Central vacuum
Each IQ, OQ, and PQ protocol provides the specific procedure to follow, information
to be recorded, a set of acceptance criteria, and a list of materials, equipment and
documents needed to perform the validation.
7.1 Installation qualification (IQ)
This document should be written for the critical processing equipment and systems
that are used within the facility, e.g. an HVAC system, an autoclave or a pH meter.
The IQ should list all the identification information, the location, utility requirements
and any safety features of the equipment.
The IQ protocol prepared for each piece of equipment or system lists the name, description,
model and identification numbers, the location, utility requirements, connections,
and any safety features of the system/equipment which need to be documented.
It should verify that the item matches the purchase specifications, and that all
drawings, manuals, spare parts list, vendor address and contact number, and other
pertinent documentation are available.
7.2 Operational qualification (OQ)
This document outlines the information required to provide evidence that all the components
-
8/2/2019 Adarsh b.r. Project
17/17
of a system or of a piece of equipment operate as specified. This involves
testing of all normal operation controls, all alarm points, all switches and displays,
interacting controls, and any other indications of operations and functions. The OQ
document should provide a listing of SOPs (or reference to specific manual instructions)
for operation, maintenance and calibration; information on the training of operators;
and instructions for any static or dynamic tests to show that the equipment
operates as expected under normal conditions. Specifications and acceptance criteria
must be defined for all the operations. The OQ document should include information
on equipment or system calibration, pre-operational activities, routine operations and
their acceptance criteria.
7.3 Performance qualification (PQ)
This part of the validation for systems and equipment is performed after both Installation
and Operational Qualifications have been completed, reviewed and approved.
The PQ document describes the procedure or procedures for demonstrating that a
system or piece of equipment can consistently perform and meet required specifications
under routine operation and, where appropriate, under worst case situations.
The PQ should include a description of the preliminary procedures required, the detailed
performance test(s) to be done, and the acceptance criteria for each test. The PQ
also requires that other supporting equipment used during the qualification have been
validated (e.g. the steam system must be validated before the autoclave can be validated.